Time New York: Sat 16 Dec 00:13 am  |  Save 15% on H&R Block Online

  
caticonslite_bm_alt

Abeona Therapeutics (ABEO) Catches Eye: Stock Jumps 5.8%

Zacks

Abeona Therapeutics Inc.ABEO was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $4.60 to $5.35 in the past one-month time frame.

The company has seen one positive revision in the past one month, while its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for this stock. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

Abeona Therapeutics currently carries a Zacks Rank #3 (Hold), while its Earnings ESP is negative.

Abeona Therapeutics Inc. Price


Abeona Therapeutics Inc. Price | Abeona Therapeutics Inc. Quote

A better-ranked Medical – Biomedical and Genetics stock is Cellectis S.A. CLLS, sporting a Zacks Rank #1 (Strong Buy).You can see the complete list of today’s Zacks #1 Rank stocks here.

Is ABEO going up? Or down? Predict to see what others think: Up or Down

Zacks' Top Investment Ideas for Long-Term Profit

How would you like to see our best recommendations to help you find today’s most promising long-term stocks? Starting now, you can look inside our portfolios featuring stocks under $10, income stocks, value investments and more. These picks, which have double and triple-digit profit potential, are rarely available to the public. But you can see them now. Click here >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.